Medtronic InFuse Sales Flat In Q2; Firm’s Spine Business Still Struggling
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is exploring alternative distribution channels in oral maxillofacial and trauma markets to grow its struggling InFuse bone graft franchise, the firm said during its Nov. 18 fiscal second-quarter earnings call